Excessive nitric oxide attenuates leptin-mediated signal transducer and activator of transcription 3 activation

Life Sci. 2007 Jan 23;80(7):609-17. doi: 10.1016/j.lfs.2006.10.007. Epub 2006 Oct 20.

Abstract

The mechanisms of leptin resistance observed in most cases of human obesity are poorly understood. Therefore, we evaluated the effects of nitric oxide (NO) on the leptin-induced activation of Janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) pathways and on the leptin receptor (LEPR) expression using SH-SY5Y cells. Here, we show that the NO donor spermine/NONOate inhibited leptin-induced activation of STAT3 in vitro. The inhibition of leptin-mediated STAT3 phosphorylation caused by excessive NO was partially prevented by a sulfhydryl reducing agent, ascorbic acid. Cellular experiments show that reduced expression of long form leptin receptor (LEPR-b) and STAT3 protein instability induced by NO may be mechanisms of the NO-mediated inhibition of leptin-STAT3 signaling. We also present data showing that the hypothalamic NO content of high-fat (HF)-diet-induced obese mice was higher than that of control mice; this is likely caused by decreased caveolin-1 expression and increased nNOS expression induced by HF diet over 19 weeks. Concurrently with the overproduction of NO, the decrease of hypothalamic LEPR-b in obese mice also supports these in vitro data. Combined results suggest that excess of NO can induce the attenuation of leptin-mediated STAT3 activation through reduced expression of LEPR-b mRNA and instability of STAT3 protein at least in part. Furthermore, our in vivo data indicate that long-term HF diet induces hypothalamic overproduction of NO, which may be related with leptin insensitivity. However, further study is required to warrant direct in vivo evidence of a causal relationship between endogenous excess of hypothalamic NO and central leptin resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ascorbic Acid / pharmacology
  • Caveolin 1 / metabolism
  • Cell Line, Tumor
  • Dietary Fats / administration & dosage
  • Down-Regulation / drug effects
  • Drug Antagonism
  • Gene Expression / drug effects
  • Gene Expression / genetics
  • Humans
  • Hypothalamus / chemistry
  • Hypothalamus / metabolism
  • Leptin / antagonists & inhibitors*
  • Leptin / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neuroblastoma / drug therapy
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology
  • Nitrates / analysis
  • Nitrates / metabolism
  • Nitric Oxide / metabolism*
  • Nitric Oxide Donors / pharmacology*
  • Nitric Oxide Synthase Type I / metabolism
  • Nitrites / analysis
  • Nitrites / metabolism
  • Obesity / etiology
  • Obesity / metabolism
  • Phosphorylation
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / metabolism*
  • Receptors, Leptin
  • STAT3 Transcription Factor / metabolism*
  • Spermine / analogs & derivatives*
  • Spermine / pharmacology

Substances

  • Caveolin 1
  • Dietary Fats
  • LEPR protein, human
  • Leptin
  • Nitrates
  • Nitric Oxide Donors
  • Nitrites
  • Receptors, Cell Surface
  • Receptors, Leptin
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • leptin receptor, mouse
  • spermine nitric oxide complex
  • Spermine
  • Nitric Oxide
  • Nitric Oxide Synthase Type I
  • Ascorbic Acid